U.S. market Closed. Opens in 11 hours 39 minutes

ATXS | Astria Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
RevenueN/AN/AN/AN/AN/AN/A500.00KN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/A26.00KN/AN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/A-26.00KN/AN/AN/AN/AN/AN/A
Operating Expenses67.83M53.50M30.36M37.44M27.09M26.37M27.59M35.56M31.66M21.68M18.12M
Selling, General & Admin25.70M19.24M14.81M11.85M8.77M9.33M8.91M10.11M8.63M6.00M4.12M
Research & Development42.13M34.26M15.55M25.59M18.32M17.04M18.68M25.45M23.03M15.69M13.99M
Other Operating Expenses15.20M-55.00K-58.00K-101.00K-50.00K176.00KN/AN/AN/AN/AN/A
Operating Income-67.83M-53.50M-194.98M-37.44M-27.09M-26.37M-27.09M-35.56M-31.66M-21.68M-18.12M
Other Expenses / Income-5.06M1.67M64.00K135.00K795.00K176.00K-270.00K-502.00K-971.00K-203.00K1.00K
Before Tax Income-72.89M-51.83M-194.91M-37.30M-26.29M-25.87M-27.36M-36.06M-32.63M-21.88M-18.12M
Income Tax Expenses15.20K-1.67M-164.74M-236.00K-50.00K601.00KN/AN/AN/AN/AN/A
Net Income-72.89M-50.16M-30.17M-37.06M-26.24M-25.87M-27.36M-36.06M-32.63M-21.88M-18.12M
Interest ExpensesN/A-1.67MN/AN/AN/A100.00K462.00K837.00K978.00K206.00KN/A
Basic Shares Outstanding30.12M14.62M8.93M3.06M1.87M842.47K361.36K270.50K134.03K140.62K144.42K
Diluted Shares Outstanding30.12M14.62M8.93M3.06M1.87M842.47K361.36K270.50K134.03K140.62K144.42K
EBITDA-67.83M-53.50M134.26M-37.44M-26.27M-25.65M-26.60M-34.83M-31.45M-21.43M-17.80M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%-5,319.60%0.00%0.00%0.00%0.00%
EBIT-72.88M-53.50M-194.91M-37.30M-26.29M-25.17M-26.90M-35.22M-31.65M-21.68M-18.12M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%-5,380.40%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙